Rossano Cesari Selected Research

Glucosinolates

4/2002

Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rossano Cesari Research Topics

Disease

13	Neoplasms (Cancer) 04/2024 - 04/2002
3	Carcinoma (Carcinomatosis) 04/2024 - 04/2004
3	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2003
3	Triple Negative Breast Neoplasms 01/2023 - 10/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2004 - 09/2004
2	Carcinogenesis 09/2004 - 04/2002
1	Non-Muscle Invasive Bladder Neoplasms 12/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Fibroma (Fibromatosis) 03/2018
1	Aggressive Fibromatosis (Desmoid) 03/2018
1	Fatigue 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2008
1	beta-Thalassemia (Cooley's Anemia) 07/2008
1	Anemia 07/2008
1	alpha-Thalassemia 07/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2004
1	Infections 11/2004
1	Necrosis 04/2002
1	T-Cell Leukemia (Leukemia, T Cell) 04/2002
1	Leukemia 04/2002

Drug/Important Bio-Agent (IBA)

3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2018 - 01/2015
3	nirogacestatIBA 03/2018 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 11/2008 - 09/2004
3	Histidine (L-Histidine)FDA Link 11/2004 - 02/2003
2	avelumabIBA 04/2024 - 01/2023
2	Sunitinib (Sutent)FDA Link 03/2014 - 10/2013
2	Complementary DNA (cDNA)IBA 11/2004 - 04/2004
1	Cisplatin (Platino)FDA LinkGeneric 04/2024
1	Pemetrexed (MTA)FDA Link 04/2024
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	Gemcitabine FDA Link 04/2024
1	LigandsIBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	AntigensIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	PlatinumIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	talazoparibIBA 01/2023
1	CateninsIBA 03/2018
1	utomilumabIBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2017
1	glasdegibIBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 03/2014
1	Phosphotransferases (Kinase)IBA 11/2008
1	Hemoglobins (Hemoglobin)IBA 07/2008
1	beta-Globins (beta Globin)IBA 07/2008
1	DNA (Deoxyribonucleic Acid)IBA 08/2007
1	fragile histidine triad proteinIBA 11/2004
1	NitrosaminesIBA 11/2004
1	Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA 11/2004
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 11/2004
1	OligodeoxyribonucleotidesIBA 09/2004
1	diadenosine polyphosphate hydrolaseIBA 02/2003
1	TransferasesIBA 02/2003
1	NucleosidesIBA 02/2003
1	HydrolasesIBA 02/2003
1	sulforaphaneIBA 04/2002
1	glucoraphaninIBA 04/2002
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 04/2002
1	GlucosinolatesIBA 04/2002
1	isothiocyanic acidIBA 04/2002
1	EnzymesIBA 04/2002
1	CarcinogensIBA 04/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2024 - 10/2013
2	Therapeutics 07/2008 - 09/2004
1	Transurethral Resection of Bladder 12/2023
1	Immunotherapy 12/2023
1	Castration 01/2023
1	Oral Administration 01/2015
1	Transplantation 07/2008
1	Aftercare (After-Treatment) 11/2004